Rheumatic Heart Disease in Children Carried a Heavy Hospital and Household Cost in the RHYTHM Study
Acute rheumatic fever and rheumatic heart disease continue to exact a steep price in children from underprivileged communities, and the RHYTHM Study makes that burden tangible in clinical and economic terms. In this cohort, illness was not confined to valve damage or repeated admissions. It disrupted schooling, consumed family income, and, in a substantial share of cases, ended in surgery.
The study examined 48 children admitted with acute rheumatic fever or rheumatic heart disease and tracked 70 hospital admissions in total. The mean age was 11.3 ± 3.1 years, placing the disease squarely in childhood rather than late adolescence. A large share of admissions were driven by decompensated heart failure, and that detail matters clinically because it signals advanced disease rather than incidental detection. Once heart failure appears, the condition is no longer a quiet murmur on examination; it becomes a repeated inpatient problem with direct consequences for survival, schooling, and household finances.
Heart Failure Dominated the Admission Pattern
Forty-six admissions, or 66%, were for decompensated heart failure. First-episode acute rheumatic fever accounted for 19 admissions, while recurrence accounted for 17. The pattern points to two overlapping clinical realities: children are arriving sick enough to require hospitalization, and recurrence remains a major driver of further decompensation. In rheumatic disease, ongoing valve injury and inflammatory sequelae can progressively reduce cardiac reserve, so repeated episodes of heart failure are not surprising when secondary prevention and early treatment fail to interrupt the disease course.
The surgical burden was also substantial. Thirty-one children, 64% of the cohort, underwent surgery, and two postoperative deaths were recorded, representing 6% among those who had surgery. For a pediatric population, that is a stark marker of severity. Surgery in rheumatic heart disease often reflects advanced valvular damage that has already outpaced medical management, and postoperative mortality, even in a small cohort, reinforces how late many children enter the surgical pathway.
One sentence captures the clinical pressure behind the numbers: this was not a mild disease burden being managed conservatively.
School Time Vanished Alongside Bed Days
The mean hospital stay was 11.5 ± 5 days, a prolonged admission by any pediatric standard. Hospital time alone, however, only partially reflects the burden. Children lost an average of 230 ± 128 school days, an especially consequential outcome in a disease that often strikes during the most formative educational years. Prolonged absenteeism can affect academic progression, social development, and future opportunity, while frequent admissions can make regular attendance unrealistic.
That educational loss also tracks with disease chronicity. Children with rheumatic heart disease often face repeated appointments, investigations, medication schedules, and surgical follow-up. When admissions recur, schooling becomes collateral damage. The study’s school-day data turn an abstract morbidity statistic into a real-life measure of childhood disruption.
Household Income Was Small Compared With the Cost of Care
The family profile in the study shows why the disease becomes financially punishing so quickly. Average household size was 5.2 ± 1.2 members, with 2.89 ± 0.96 children per family. In 24 families, or 50%, both parents were earning. The average daily household income was ₹625 ± 210. Those figures reflect families living with narrow financial margins, where even brief hospitalization can reverberate through rent, food, transport, and school costs.
Eighty-eight percent of families belonged to the upper lower-middle socioeconomic class. In practical terms, that places most households in a bracket that is neither insulated from medical expenses nor easily able to absorb prolonged out-of-pocket payment. The study focused on total healthcare costs, out-of-pocket expenditure, and the resulting financial impact, which is exactly the right lens for a disease like rheumatic heart disease. In low-resource settings, the economic injury is often as consequential as the valve lesion itself.
Health systems often discuss catastrophic expenditure in broad policy language. Here, the family structure and income data show how quickly that catastrophe can become personal.
Why Rheumatic Disease Still Breaks Families Economically
The mechanism is straightforward, even when the social consequences are not. Recurrent inflammation after acute rheumatic fever can injure cardiac valves, and valve dysfunction then drives heart failure, hospitalization, imaging, medication use, and in many children, surgery. Each step adds cost. Each admission removes a parent from work, pulls a child from school, and often requires travel and repeated follow-up. When the disease affects children from lower-income households, the financial shock is multiplied because the family has less reserve to absorb it.
The RHYTHM Study is valuable because it measures more than clinical severity. It links disease phenotype with real-world burden: long admissions, recurrent decompensation, substantial surgical need, school loss, and high economic strain. Those are the outcomes that families feel first, even before a clinician tallies valve gradients or operative indications.
The study also sharpens the case for earlier detection and prevention. Preventing recurrence of acute rheumatic fever, recognizing valve disease before heart failure becomes established, and avoiding delays in referral could reduce a portion of the downstream burden captured in this cohort. Once decompensation and surgery enter the picture, the cost is no longer limited to the hospital bill. It spreads across the child’s education and the family’s livelihood.
A Disease Measured in Admissions, Operations, and Days Lost
The RHYTHM Study makes one point unmistakable: pediatric rheumatic heart disease remains a disease of deep clinical and economic consequence in vulnerable populations. The children in this cohort were young, frequently hospitalized for heart failure, often surgical candidates, and burdened by extended school absence. Families were already living on limited incomes, which makes out-of-pocket spending especially hazardous.
Two postoperative deaths occurred after surgery, a reminder that advanced rheumatic disease still carries meaningful procedural risk. The study does not soften that reality. It shows a condition that continues to demand hospital beds, operating rooms, and household sacrifices in equal measure, with the greatest price paid by children who lose both health and schooling at the same time.